LASHAWNDA CAMPBELL: Open Payments
NPI 1730941477 · PINEHURST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,747 in 55 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,597 · 2025 $1,747
Food & beverage: $1,747
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $752 |
| Pharmacosmos Therapeutics Inc. | 2 | $173 |
| Janssen Biotech, Inc. | 3 | $157 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $148 |
| Gilead Sciences, Inc. | 2 | $139 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $77 |
| Lilly USA, LLC | 3 | $57 |
| QOL Medical, LLC | 2 | $42 |
| Ipsen Biopharmaceuticals, Inc | 2 | $41 |
| Ardelyx, Inc. | 2 | $37 |
Products named: RINVOQ, SKYRIZI, MONOFERRIC, TREMFYA, XIFAXAN, Livdelzi, LINZESS, ENTYVIO.
Industry payments across NC — which companies pay providers there.
